Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.
about
Gene therapy in Parkinson's disease: rationale and current statusThe role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophyA new generation of human artificial chromosomes for functional genomics and gene therapyDrug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeuticsCurrent and future pharmacological treatment strategies in X-linked adrenoleukodystrophyTransfusion independence and HMGA2 activation after gene therapy of human β-thalassaemiaA transposon and transposase system for human applicationLentiviral vector gene therapy: effective and safe?Clinical development of gene therapy: results and lessons from recent successesProduction of lentiviral vectorsCurrent and future alternative therapies for beta-thalassemia majorGene Therapy in Cardiac Surgery: Clinical Trials, Challenges, and PerspectivesGene therapy: progress and predictionsPeroxisomes in brain development and functionAdvanced cell therapies: targeting, tracking and actuation of cells with magnetic particlesCell-based therapy technology classifications and translational challengesBone Marrow Gene Therapy for HIV/AIDSDevelopments in the treatment of hemophilia B: focus on emerging gene therapyState-of-the-art human gene therapy: part I. Gene delivery technologiesDifferential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosisThe genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosisA short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiformePerinatal systemic gene delivery using adeno-associated viral vectorsHematopoietic stem cell gene therapy:assessing the relevance of preclinical modelsNucleic acid therapy for lifespan prolongation: present and futureRetroviral integrations in gene therapy trialsHematopoietic stem cell engineering at a crossroadsAdvances in understanding and treating dystrophic epidermolysis bullosaGene therapy on the moveNeural stem cells could serve as a therapeutic material for age-related neurodegenerative diseasesAdvances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disordersIs genetic rescue of cystinosis an achievable treatment goal?Current translational and clinical practices in hematopoietic cell and gene therapyAllele-specific silencing of mutant huntingtin in rodent brain and human stem cellsABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human DiseaseGenetically modified mesenchymal stromal cells in cancer therapyRetroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectivesIdentifying Cancer Driver Genes Using Replication-Incompetent Retroviral VectorsManufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapiesIn vivo genome editing restores haemostasis in a mouse model of haemophilia
P2860
Q22241423-CD62EE63-0634-4111-9B03-72D492F7ED91Q24300003-D999F64A-8DB6-4EA6-B4B8-7C174C5CA7A9Q24599954-5416E390-DD00-4A72-8549-4FB8D8761B7AQ24616751-9C7DF2DF-9D14-4A25-BCDD-5EDBA17DA936Q24618949-068D220E-FDA5-4D01-83B1-7481920345A1Q24618997-2AA56225-5D57-4A5C-B618-83C01605706BQ24630047-C06856F0-2E8F-42A1-B892-1F2DB75D6D91Q24630888-C135A206-B760-446D-A1CB-D51A67BFE889Q26743393-BC63699A-66C0-4DE4-9B13-A8EB0AD10D29Q26750586-411A4488-AA65-4BF3-A0CA-954D72EC85C8Q26750906-47C45C69-C262-4AF8-95A6-FE71DD0E5D61Q26769595-56A7CF97-97FD-4476-BCA1-35FA12D1705DQ26772109-FCD907FA-87B8-4E4C-9FDD-A56B01FCBC01Q26774697-049909C1-A7B5-4FF5-BC72-C4C465484925Q26782710-75248326-F5B1-46AE-89F7-DA1E6E5F669CQ26785346-DA8A60CC-F0EA-40B4-99FB-8BB862BA428FQ26801765-3F37177B-B30C-45E7-8169-240F499ABF90Q26823376-2C150324-1D1B-4FA9-BFD9-A4E89535C842Q26825575-71B5A5E8-7BC7-4610-8589-A259A8742032Q26827402-7170F4C0-D559-4FB5-8F70-C635CC217F54Q26829999-3F4E521E-E25D-435E-A4BC-6ED6B85A21DAQ26849375-4471D755-818D-4D5D-838E-A17BE0B798CAQ26852989-91F67092-1BD9-48F0-8955-F8BFCD2B6CB8Q26859147-3CDF1DDA-5941-47D5-8709-7623056003C4Q26861654-C9E6A9BF-F2CD-4EC7-B1CC-1F0C1D0825BAQ26991660-C858909B-86FE-43FA-95F1-8DA67AD4344FQ27001570-36413C04-CD69-436C-BE31-8C108CBB28E7Q27006669-F1AE3AFC-D8CA-484D-9B07-5A6C69E32286Q27007012-A8A4A77B-1587-4B09-978C-07478EB4615DQ27021719-B030A298-3FE5-4997-888E-CD44C5CBFC74Q27022561-9C4D67D5-CD67-4B05-B49C-3F135E599172Q27023975-91695CBD-3701-4A19-80D2-F473D8B1CD8DQ27024456-B0983D37-970D-4328-99A2-8BB086D4D2A5Q27324212-D5FF8BB1-663A-46BB-9FB9-DF46810457E6Q28068772-3E2E7B4A-CC81-4EE5-94EC-966996546803Q28071840-A7AE9348-2BC3-4E27-BE6A-F916EA957FFBQ28074002-421038B3-3AA7-4E32-A920-930F1FC2E0E8Q28077919-7792D88E-3EE3-48C4-AD8A-BCB4187254EBQ28085769-86F939AB-2756-470F-B194-BF0D01355A10Q28241725-3F58F97A-D5BB-41C7-B670-4A9A707872C3
P2860
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hematopoietic stem cell gene t ...... X-linked adrenoleukodystrophy.
@ast
Hematopoietic stem cell gene t ...... X-linked adrenoleukodystrophy.
@en
type
label
Hematopoietic stem cell gene t ...... X-linked adrenoleukodystrophy.
@ast
Hematopoietic stem cell gene t ...... X-linked adrenoleukodystrophy.
@en
prefLabel
Hematopoietic stem cell gene t ...... X-linked adrenoleukodystrophy.
@ast
Hematopoietic stem cell gene t ...... X-linked adrenoleukodystrophy.
@en
P2093
P50
P356
P1433
P1476
Hematopoietic stem cell gene t ...... X-linked adrenoleukodystrophy.
@en
P2093
Bruno l'Homme
Cynthia C Bartholomae
Céline Bellesme
Denice Mittelstaedt
François Lefrère
Gabor Veres
Ina Kutschera
Liliane Dal-Cortivo
Manfred Schmidt
Michel Vidaud
P304
P356
10.1126/SCIENCE.1171242
P407
P50
P577
2009-11-01T00:00:00Z